Jan 22, 2024MitoSense Inc. Completes $3.5 Million Series Seed Funding Round, Led by Caydan Capital PartnersPLYMOUTH, Mass., Jan. 22, 2024 /PRNewswire/ -- MitoSense Inc., a research and development company focused on neurodegenerative disease...
Oct 11, 2023WRAIR, VA and MitoSense Announce CRADA to Develop Novel Prehospital Treatment for TBIPLYMOUTH, Mass. and TAMPA, Fla. and SILVER SPRING, Md., Oct. 11, 2023 /PRNewswire/ -- MitoSense, Inc., the James A. Haley Veterans'...
Aug 7, 2023Greenwood Genetic Center Receives Funding for Alzheimer's ResearchWHNS Fox Carolina reported on the Greenwood Genetic Center receiving $2 million for Alzheimer's Disease research. This funding is...
Jul 24, 2023MitoSense Joins CAMP as Partner for Advanced Therapy Medicinal Products (ATMPs) DevelopmentPLYMOUTH, Mass., July 24, 2023 /PRNewswire/ -- MitoSense and the Centre for Advanced Medical Products (CAMP) are delighted to announce...
Feb 20, 2023Funding for mitochondrial treatment research on Alzheimer’s disease in SC Governor's budget proposalGREENWOOD, S.C. (FOX Carolina) -- The Greenwood Genetics Center in Greenwood, SC is looking to study MitoSense's MOT™ technology and its...
Dec 21, 2022MitoSense and Uppsala University's Centre for Transplantation Technology Enter into Strategic MOUGREAT FALLS, Va., Dec. 21, 2022 /PRNewswire/ -- Today, Uppsala University's Centre for Transplantation Technology (CTTM) and US-based...
Sep 12, 2022MitoSense and U.S. Dept. of Veterans Affairs Selected to Present Science at Major Medical ConferenceGREAT FALLS, Va., Sept. 12, 2022 /PRNewswire/ -- MitoSense, Inc., a life-science company focused on harnessing the power of mitochondria...